Toggle navigation
Home
Pulse
Channels
CME
Profile
Home
Pulse
Channels
CME
Profile
Shivangini Duggal's Talks
Shivangini Duggal
Texas Tech University Health Sciences Center, El Paso, TX
Duration of Therapy Beyond CR
July 7, 2025
Shivangini Duggal
Texas Tech University Health Sciences Center, El Paso, TX
The Validity of mRECIST in Immunotherapy
July 7, 2025
Share
The Validity of mRECIST in Immunotherapy
https://www.medspoke.co/channel_playlist?object_id=785&tap_id=9558
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Shivangini Duggal
Texas Tech University Health Sciences Center, El Paso, TX
Survival Outcomes Following CR
July 7, 2025
Why are you reporting this TALK?
